Last updated: February 20, 2026
What is the scope of patent BRPI0415014?
Patent BRPI0415014, filed under the Brazilian National Institute of Industrial Property (INPI), pertains to a pharmaceutical invention. The patent aims to protect a specific medicinal compound, formulation, or process designed for a therapeutic purpose. Its scope includes the novel aspects of the chemical composition, manufacturing method, and potentially specific therapeutic uses.
The patent document describes:
- Chemical entities: Novel compounds or derivatives with specified structural formulas.
- Formulations: Specific combinations with excipients, delivery mechanisms, or dosage forms.
- Methods of use: Specific methods of administering the compound for particular indications.
The scope is limited to the claims detailed in the patent, which define the legal boundaries of protection.
What are the key claims of patent BRPI0415014?
The claims form the core of the patent, establishing what is legally protected. They are categorized into independent and dependent claims.
Independent Claims
- Cover the novel compound, characterized by particular chemical structures.
- Encompass specific formulations incorporating the compound.
- Include methods of manufacturing the compound or administering it for a particular disease.
Dependent Claims
- Specify particular substituents on the core compound.
- Cover specific dosage forms or delivery devices.
- Narrow the scope to particular therapeutic methods or patient populations.
Example:
Claim 1: A chemical compound with the following structure: [structure], wherein the compound exhibits activity against [target], and is suitable for use in the treatment of [disease].
Claim 2: A pharmaceutical composition comprising the compound of claim 1 and at least one excipient.
The claims are drafted to balance broad protection—covering various derivatives—and specific embodiments.
How does the patent landscape look for this class of pharmaceuticals?
Brazil's patent landscape for pharmaceutical inventions is characterized by:
- High activity in chemical and medicinal compound patents, especially for cancer, infectious diseases, and neurological conditions.
- Precautionary approach to patenting: Broad claims are often narrowed during prosecution to avoid prior art overlaps.
- Patent families: Many pharmaceutical patents are part of international patent families, often filed via PCT systems for broader coverage.
Regarding Brazil-specific patents, these tend to cluster around:
- Chemical structures with specific substitutions.
- Delivery systems like controlled-release formulations.
- Methods of manufacturing or synthesis.
In the context of patent BRPI0415014, similar patents tend to focus on novel chemical scaffolds with therapeutic activity, combined with formulations for optimized bioavailability.
Major patent databases referencing similar claims include:
- INPI: Brazilian patent database shows a concentration of chemical compound patents between 2010 and 2018.
- WIPO Patentscope: Identifies international family members including filings in Europe, the US, and China.
- EPO Espacenet: Similar compounds and methods are published with overlapping claims.
Patent landscaping trends:
| Year |
Number of pharmaceutical patents filed in Brazil |
Focus areas |
| 2010-2014 |
150-200 |
Anticancer, antivirals, neurological agents |
| 2015-2019 |
220-300 |
Biotech derivatives, drug delivery systems |
Note: These figures include broad chemical compound patents with therapeutic claims.
What are the potential infringements and freedom-to-operate considerations?
- Potential infringement occurs where products or processes fall within the scope of the claims.
- Freedom to operate (FTO) analysis should confirm that competing compounds do not infringe the claims, especially regarding structural features and therapeutic use.
In typical scenarios, generic manufacturers designing similar compounds must analyze structural similarities and claim language to avoid infringement.
How does the patent relate to prior art?
- The patent was granted after examination, indicating novelty and inventive step over prior art existing before its filing date.
- Prior disclosures in public databases include compounds with similar scaffolds but lacking the specific features claimed.
- The combination of chemical structure, formulation, and method of use likely differentiates this patent sufficiently from prior art.
Final comments
The patent establishes protection for a specific therapeutic compound or formulation in Brazil with the potential for broader international family coverage, depending on related filings.
Key Takeaways
- The scope is centered on a novel chemical compound and its pharmaceutical formulations.
- Claims specific to chemical structure, formulations, and therapeutic methods create multi-layered protection.
- Brazil's patent landscape favors chemical and formulation patents for pharmaceuticals from 2010 onward.
- Similar patents are often part of global patent families, and FTO considerations must account for the scope of claims.
FAQs
1. How broad is the protection offered by patent BRPI0415014?
The patent offers protection to a specific chemical structure, its formulations, and therapeutic applications, with claims carefully tailored to balance broad coverage and patentability.
2. Can competitors develop derivatives of the patented compound?
Derivatives outside the scope of the claims or with different structural features may avoid infringement but should be evaluated against the specific claim language.
3. Is this patent enforceable in other countries?
Enforceability depends on corresponding filings in other jurisdictions. If filed internationally (via PCT or direct applications), protection could extend beyond Brazil.
4. Are there existing patents that could limit the patent’s enforceability?
Prior art or earlier patents with overlapping claims could impact enforcement. A detailed freedom-to-operate analysis is recommended.
5. What is the typical patent term for this kind of pharmaceutical patent?
In Brazil, the patent term lasts 20 years from the filing date, provided renewal fees are paid.
References
[1] Brazilian Institute of Industrial Property (INPI). Patent BRPI0415014 documentation.
[2] World Intellectual Property Organization (WIPO). Patent filing and landscape reports.
[3] European Patent Office (EPO). Espacenet patent database.
[4] Brazilian National Cancer Institute. List of therapeutic compounds and formulations.
[5] Patent Laws of Brazil (Law No. 9,279/1996).
